ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,770.20
      0.55%
      US Tech 100
      19,636.04
      0.55%
      Dow Jones
      42,801.72
      0.52%
      Brent Oil
      70.235
      0.00%
      Bitcoin
      86,258.15
      -0.57%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. GenSight Biologics S.A. (SIGHT) Quote

      GenSight Biologics S.A.

      GenSight Biologics S.A. (SIGHT)

      EU
      0.256
      0.044
      (20.75%)
      Closed March 08 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.256
      Bid
      0.245
      Ask
      0.258
      Volume
      716,631
      0.215 Day's Range 0.26
      0.2005 52 Week Range 0.515
      Market Cap
      20.063M
      Previous Close
      0.212
      Open
      0.2155
      Last Trade
      5
      @
      0.256
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      229,494
      Shares Outstanding
      78,370,724
      Dividend Yield
      -
      PE Ratio
      -0.78
      Earnings Per Share (EPS)
      -0.33
      Revenue
      2.96M
      Net Profit
      -26.22M

      About GenSight Biologics S.A.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.gensight-biologics.com
      Headquarters
      Paris, Paris, Fra
      Founded
      -
      GenSight Biologics S.A. is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker SIGHT. The last closing price for GenSight Biologics was 0.21 €. Over the last year, GenSight Biologics shares have traded in a share price range of 0.2005 € to 0.515 €.

      GenSight Biologics currently has 78,370,724 shares outstanding. The market capitalization of GenSight Biologics is 16.61 € million. GenSight Biologics has a price to earnings ratio (PE ratio) of -0.78.

      Ask ADVFN Intelligence (AI)

      SIGHT Latest News

      More News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.0062.40.250.260.20052039520.22112688DE
      4-0.056-17.94871794870.3120.3120.20052161420.26134509DE
      12-0.0605-19.11532385470.31650.3230.20052294940.27940415DE
      26-0.113-30.62330623310.3690.4480.20052895420.32287325DE
      52-0.206-44.58874458870.4620.5150.20052335510.34751883DE
      156-2.568-90.93484419262.8244.5880.20052110641.09261744DE
      260-2.104-89.15254237292.369.690.20052661223.09212994DE

      SIGHT - Frequently Asked Questions (FAQ)

      What is the current GenSight Biologics share price?
      The current share price of GenSight Biologics is 0.256 €
      How many GenSight Biologics shares are in issue?
      GenSight Biologics has 78,370,724 shares in issue
      What is the market cap of GenSight Biologics?
      The market capitalisation of GenSight Biologics is EUR 16.61M
      What is the 1 year trading range for GenSight Biologics share price?
      GenSight Biologics has traded in the range of 0.2005 € to 0.515 € during the past year
      What is the PE ratio of GenSight Biologics?
      The price to earnings ratio of GenSight Biologics is -0.78
      What is the cash to sales ratio of GenSight Biologics?
      The cash to sales ratio of GenSight Biologics is 6.88
      What is the reporting currency for GenSight Biologics?
      GenSight Biologics reports financial results in EUR
      What is the latest annual turnover for GenSight Biologics?
      The latest annual turnover of GenSight Biologics is EUR 2.96M
      What is the latest annual profit for GenSight Biologics?
      The latest annual profit of GenSight Biologics is EUR -26.22M
      What is the registered address of GenSight Biologics?
      The registered address for GenSight Biologics is 74, RUE DU FAUBOURG SAINT-ANTOINE, PARIS, PARIS, 75012
      What is the GenSight Biologics website address?
      The website address for GenSight Biologics is www.gensight-biologics.com
      Which industry sector does GenSight Biologics operate in?
      GenSight Biologics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALEUPEuroplasma
      0.02 €
      (78.57%)
      		29.84M
      MLAZRThe Azur Selection SA
      1.13 €
      (61.43%)
      		47.07k
      ALCYBCybergun
      0.0003 €
      (50.00%)
      		290.89M
      ALJXRArchos
      0.241 €
      (37.71%)
      		524.29k
      ALDOLDolfines
      3.21 €
      (29.96%)
      		52.87k
      DMSBSDiagnostic Medical Systems
      0.0015 €
      (-81.25%)
      		14.15k
      BNBSTonner Drones
      0.002 €
      (-42.86%)
      		1.61M
      TDBSTonner Drones
      0.0038 €
      (-41.54%)
      		23.76M
      BUIBarbara Bui
      3.10 €
      (-24.39%)
      		1.05k
      MLTROTroc de l Ile
      2.50 €
      (-20.38%)
      		60
      ATOAtos SE
      0.0046 €
      (-6.12%)
      		5.99B
      ALCYBCybergun
      0.0003 €
      (50.00%)
      		4.22B
      ALEUPEuroplasma
      0.02 €
      (78.57%)
      		365.72M
      ALTDTonner Drones
      0.027 €
      (-20.12%)
      		282.8M
      BCPBanco Comercial Portugues SA
      0.5538 €
      (2.44%)
      		91.6M

      Discussion

      View Full Feed
      Seminole Red Seminole Red 12 minutes ago
      State AG Sets Stage to Have All Biden Pardons, Exec Orders, Other Actions Legally Voided

      https://www.msn.com/en-us/news/politics/state-ag-sets-stage-to-have-all-biden-pardons-exec-orders-other-actions-legally-voided/ar-AA1Au3Ef?ocid=msedgntp&pc=HCTS&cvid=f60c7988508b4d79a176c6fa3203fd
      luvwetscent luvwetscent 14 minutes ago
      OK..one short one..in over 50 years of investing I've never seen a single stock that did not respond to buyout talk that was more than rumor...and when the CEO himself begins talking about it?...up up goes the SP
      ELTP
      Seminole Red Seminole Red 21 minutes ago
      I dunno, DeSantis will come up with something but im sure alot wont like it when they start losing tax money that they think they are entitled to.....Why is receiving tax money an Entitlement, nothing is Entitled, it can be revoked By the people through voting.
      MrHappySmoke MrHappySmoke 22 minutes ago
      DB, desktop, chazzy, others may be insiders but you’re still a Loser !!! Get a life ahahahah ur going on like a 5yo child who had his candy taken away. Stfu lol. Talking about spitting in peoples faces. Seriously? You invested in a penny stock and read billboards! Wtf do you expect??
      VPLM
      luvwetscent luvwetscent 25 minutes ago
      I'm too tired to respond...."can't sleep"
      ELTP
      Heisgreater Heisgreater 30 minutes ago
      I love that song banana Man. Us old guys sure have been blessed with lots of good music from those years gone by. Hold on to those shares with both hands and teeth LOL
      Kong wantabe
      Tick tock BAM 💥
      KBLB
      Cologne9672 Cologne9672 38 minutes ago
      The case is in Nevada bankruptcy court. The link is not easily obtainable
      CRGP
      boi568 boi568 39 minutes ago
      I think that name is just a corruption of blarcamesine.
      AVXL
      jhdf51 jhdf51 41 minutes ago
      Great post and truth.
      COOP
      jhdf51 jhdf51 42 minutes ago
      Yep
      COOP
      Sheepdog Sheepdog 46 minutes ago
      Anybody with A MASTERS DEGREE LIKE MEOMG! A masters degree? Wow! Everybody knows that once you get a master's degree then you know more about everything than everybody else, right?

      Does mommy and daddy know how badly they wasted their money on the MS in basket weaving?
      GCAN
      Demolition Man Demolition Man 48 minutes ago
      News!! It happened it finally happened!! Cheers everyone see ya at the Elk Creek tavern! First round on me!!

      https://www.accessnewswire.com/newsroom/en/niocorp-finalizes-plans-to-develop-nebraska-niobium-project-413659
      NB
      4u2nv2 4u2nv2 48 minutes ago
      Moderators on this board. Please remove my last 2 posts here. I just noticed something that could possibly make them inaccurate. Thanks.
      IFUS
      flipper44 flipper44 56 minutes ago
      You continue to misstate my position. Is that fun?
      NWBO
      Sheepdog Sheepdog 57 minutes ago
      The Only Thing the CEO said is that he is exploring a merger deal....he never said he had one......Correct. He said he was thinking about it. The person saying he has a merger deal, dozens of times, is YOU!
      GCAN
      JMCK6193 JMCK6193 58 minutes ago
      So that's what your wife meant by spit-on-that-thing. 😁
      NXPL
      rx7171 rx7171 1 hour ago
      Ok
      Where is their source?
      I don’t recall the company telling us that.

      The process of arriving at a name is a complicated process requiring agency approval so to not have conflicts with other approved drugs or use elements associated with non central nervous system disord
      AVXL
      price_and_volume price_and_volume 1 hour ago
      Were my questions too hard?

      They were specific, and easy to answer, and directed at you. You saw them & publicly avoided them.

      Why would you do that, if you felt they were legit / appropriate questions to ask another in a public forum?

      We're both paid-up
      HMBL
      skitahoe skitahoe 1 hour ago
      Can you show me other companies with approved blockbuster products that doesn't have a market cap going into at least a few billion dollars.

      When this company has earnings in the billions do you still think the share price will be under $1, or will you be saying it won't go over $10,
      NWBO
      spdpro spdpro 1 hour ago
      Thanks > I need to chew on that one for a while
      EmpressMonk25 EmpressMonk25 1 hour ago
      Boiler room... LOL!
      HMBL
      Echo115 Echo115 1 hour ago
      FOLLOW THE MONEY!
      WITH OVER A BILLION SHARES MAX THE CEO IS ONE OF THE LARGEST SHAREHOLDERS! IN TRICASCADE..
      IN ADDITION TO HIS OVERWHELMING PIPELINE OF TECH PRODUCTS MAX HAS CONTACTS WITH MANY OF THE WORLDS LARGEST TECH COMPANIES INCLUDING COMPANIES LIKE MICROSOFT AND T-MOBILE..
      SRMX
      Investor082 Investor082 1 hour ago
      $90M annual revenue BS clock starts soon. No excuses like your buddy Greg Zivic, OK? ;)
      NWBO

      Your Recent History

      EU
      SIGHT
      GenSight Biologics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads